Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
11/2004
11/17/2004CN1546487A Process for preparing N-alkyl-3,4-(methylene dioxy) aniline through reduction-alkylation of 3,4-( methylene dioxy) nitrobenzene
11/16/2004US6818775 Treatment of skin-related diseases or prevention of certain undesired side effects of administered retinoids
11/16/2004US6818660 Calcilytic compounds
11/16/2004US6818635 For therapy of bacterial infections and neoplasms,
11/11/2004WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004WO2004072091B1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates
11/11/2004WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004WO2004052919A3 Peptide deformylase inhibitors
11/11/2004US20040224928 For therapy of bacterial infections and neoplasms,
11/10/2004EP1474385A1 Urea linker derivatives for use as ppar modulators
11/10/2004EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
11/10/2004CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/10/2004CN1544431A Optical activity cyclic carbonates preparation method
11/04/2004WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004WO2004004657A3 Hiv integrase inhibitors
11/04/2004US20040220433 Process for the preparation of propylene glycol
11/04/2004US20040220241 Substituted biphenyl derivatives
11/04/2004US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/03/2004EP1473287A2 Alkyldienamides exhibiting taste and sensory effect in flavor compositions
11/03/2004EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004EP1472209A2 Lipoxin a4 analogs
11/03/2004CN1543466A New use of specific cyclolignans
11/03/2004CN1543458A Preparation of a compound containing cyclic and linear carbonate groups
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004CN1543334A Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
11/03/2004CN1541993A Process for continuously preparing acetals of alpha, beta-dicarbonyl compounds
11/03/2004CN1173968C Production method of halogenated hexahydroxydiphenic derivative and its medicinal application
11/03/2004CN1173926C Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them
11/02/2004US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
10/2004
10/28/2004WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004WO2004092106A2 Process for preparing alkoxy- and aryloxy-phenols
10/28/2004WO2004092100A1 Indene derivatives as pharmaceutical agents
10/28/2004US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles
10/28/2004US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS
10/28/2004US20040214801 9-Substituted minocycline compounds
10/28/2004US20040213836 DRUG DELIVERY; prolonging the time a pharmaceutical drug circulates in the blood of a subject, comprising: introducing into the subject's bloodstream a pharmaceutical composition comprising a liposome containing inventive compound
10/28/2004CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004CA2521883A1 Indene derivatives as pharmaceutical agents
10/27/2004EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor
10/27/2004EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004EP1073428B1 Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases
10/27/2004EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004CN1539816A IL-8 receptor antagonist
10/27/2004CN1172927C Alkoxy derivative of safrole oxide 2-alkoxy-piperony ethanol and its prepn and application
10/26/2004US6809176 Compounds for use in treatment of cancer
10/26/2004US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/21/2004WO2004089928A1 Process for producing 3-cyclopropyl-3-oxopropanal acetal compound
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004WO2004089922A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties
10/21/2004WO2004071481B1 Melanogenesis inhibitor and skin preparation containing the same
10/21/2004US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide
10/21/2004US20040209872 Calcium channel blockers comprising two benzhydril moieties
10/21/2004CA2521875A1 Calcium channel blockers comprising two benzhydril moieties
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/20/2004EP1467990A1 Process for producing dioxolane nucleoside analogues
10/20/2004EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
10/20/2004EP1467695A2 Hiv integrase inhibitors
10/20/2004EP1289936B1 Substituted stilbenes as glucose uptake enhancers
10/20/2004CN1171585C Pharmaceutical preparations containing dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/14/2004WO2004087634A1 Process for production of carbonyl compounds
10/14/2004WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca)
10/14/2004US20040202760 such as 2,6-nonadienamide,N-2-propenyl-,(2E,6Z); organoleptic; for addition to foods, beverages, medicine, and toothpaste
10/14/2004US20040202619 Alkyldienamides exhibiting taste and sensory effect in flavor compositions
10/14/2004US20040200010 Dyeing keratin fibers using developer ,coupler, oxidizer
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1465879A2 Process for the preparation of tofisopam and new intermediates
10/13/2004EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc
10/07/2004WO2004085375A1 Process for the preparation of propylene glycol
10/07/2004WO2004085373A1 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound
10/07/2004US20040198991 as radiation curable monomer for ink jet inks, by ring opening a cyclic carbonate, reacting with a hydroxy-substituted cyclic carbonate, and then reacting with a(meth)acrylic acid or ester thereof to form an acrylic ester attached to the cyclic carbonate ring via a carbonate group
10/07/2004US20040198936 High hydrolytic stability; no variations in half-life; producing polyvinylidene fluoride-based polymers; thermal decomposition constants Kd (sec-1) in the presence of water are not substantially different from those in the absence of water
10/07/2004US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/06/2004EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463713A1 Prodrugs of excitatory amino acids
10/06/2004CN1534016A Calcium acceptor active compound
10/06/2004CN1169806C Producing technique for preparing beta-ethylenedioxy butyronitrile
10/06/2004CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
10/05/2004US6800766 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis
10/05/2004US6800658 A potent and safe inhibitors of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
10/05/2004CA2087035C Heterocyclic chiral ligands and method for catalytic asymmetric dihydroxylation of olefins
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 183